Published in Urology on March 01, 1999
Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol (2002) 1.74
Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol (2005) 0.84
Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma. Rev Urol (2002) 0.79
Ablation of large HCCs using a new saline-enhanced expandable radiofrequency device(). J Ultrasound (2009) 0.76
Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy. Urology (1999) 0.75
Natural history of progression after PSA elevation following radical prostatectomy. JAMA (1999) 14.35
Construction of adenovirus vectors through Cre-lox recombination. J Virol (1997) 6.72
p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (1999) 5.89
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am (2001) 5.39
Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science (1987) 4.98
Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci (2000) 3.73
Cloned pigs produced by nuclear transfer from adult somatic cells. Nature (2000) 3.51
Prostate specific antigen: a decade of discovery--what we have learned and where we are going. J Urol (1999) 3.19
Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77
DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell (2001) 2.69
Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med (1990) 2.67
Home birth in New Zealand 1973-93: incidence and mortality. N Z Med J (1997) 2.38
Crystal structure of DMSO reductase: redox-linked changes in molybdopterin coordination. Science (1996) 2.35
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology (2000) 2.35
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol (2001) 2.32
Transgastric endoscopic splenectomy: is it possible? Surg Endosc (2006) 2.26
Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev (1999) 2.24
Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res (1993) 2.22
Minimal anatomical disruption in stoma formation: the lateral rectus abdominis positioned stoma (LRAPS). Colorectal Dis (2010) 2.09
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am (1997) 2.07
Prostate-specific antigen: what's new in 1997. Oncology (Williston Park) (1997) 2.06
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol (1996) 1.98
Transgenic mouse model for skin malignant melanoma. Oncogene (1998) 1.90
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood (1990) 1.88
Measurement of the rate of nu(e) + d --> p + p + e(-) interactions produced by (8)B solar neutrinos at the Sudbury Neutrino Observatory. Phys Rev Lett (2001) 1.88
Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med (2000) 1.87
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol (1994) 1.87
Deficiency in fatty acid synthase leads to premature cell death and dramatic alterations in plant morphology. Plant Cell (2000) 1.84
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer. Urology (1997) 1.79
Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood (1996) 1.76
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol (2000) 1.72
SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene (2012) 1.70
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res (2001) 1.68
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol (1998) 1.60
Effects of exercise training on alpha-motoneurons. J Appl Physiol (1985) (2006) 1.60
Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc (1999) 1.59
Graft-versus-myeloma effect: proof of principle. Blood (1996) 1.58
Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem Pharmacol (1988) 1.56
OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology (1995) 1.56
The first step in sugar transport: crystal structure of the amino terminal domain of enzyme I of the E. coli PEP: sugar phosphotransferase system and a model of the phosphotransfer complex with HPr. Structure (1996) 1.54
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J Neurosci (2001) 1.50
Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol (1998) 1.50
Comparison of culture and microscopy in the diagnosis of Gardnerella vaginalis infection. J Clin Pathol (1982) 1.50
APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry (2005) 1.49
Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. J Urol (1997) 1.46
A role for the hepatobiliary system in IgE-mediated intestinal inflammation in the rat. Clin Exp Allergy (1999) 1.45
Mechanisms underlying the early phase of spike frequency adaptation in mouse spinal motoneurones. J Physiol (2005) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors. Am J Transplant (2013) 1.44
Comparison of Gianturco Z stents and Wallstents in a hemodialysis access graft animal model. J Vasc Interv Radiol (1995) 1.42
Identification and characterization of circulating prostate carcinoma cells. Cancer (2000) 1.41
Comparison of robotic versus human laparoscopic camera control . J Urol (1995) 1.40
Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res (1988) 1.39
Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit Rev Clin Lab Sci (1998) 1.39
Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol Pharm (2006) 1.39
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res (1984) 1.39
Impact of antimicrobial usage on antimicrobial resistance in commensal Escherichia coli strains colonizing broiler chickens. Appl Environ Microbiol (2006) 1.38
The effect of hospital volume on cancer control after radical prostatectomy. J Urol (2005) 1.36
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol (1998) 1.34
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol (2000) 1.33
Microarray analysis of microRNA expression in renal clear cell carcinoma. Eur J Surg Oncol (2009) 1.33
Partial nephrectomy: technique, complications and pathological findings. J Urol (1995) 1.30
The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells. Leukemia (2003) 1.30
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer (1997) 1.29
State-dependent hyperpolarization of voltage threshold enhances motoneurone excitability during fictive locomotion in the cat. J Physiol (2001) 1.27
Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem (2001) 1.27
Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem (2001) 1.26
Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology (2001) 1.24
Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res (1989) 1.24
Heredity and prostate cancer: a study of World War II veteran twins. Prostate (1997) 1.22
A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol (1999) 1.21
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol (1989) 1.20
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate (1999) 1.20
Influence of radical prostatectomy on serum hormone levels. J Urol (1998) 1.19
Bioimpedance: novel use of a minimally invasive technique for cancer localization in the intact prostate. Prostate (1999) 1.19
Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol (1986) 1.19
The frequency of transcriptional and translational errors at nonsense codons in the lacZ gene of Escherichia coli. Mol Gen Genet (1983) 1.18
The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol (2000) 1.17
Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience (2008) 1.17
Experimental nonfluoroscopic placement of inferior vena cava filters: use of an electromagnetic navigation system with previous CT data. J Vasc Interv Radiol (1999) 1.17
Telementoring of laparoscopic procedures: initial clinical experience. Surg Endosc (1996) 1.17
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology (2001) 1.16
Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol (1999) 1.16
Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology (1996) 1.15
Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl (1999) 1.14
Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med (1994) 1.13
Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology (2000) 1.12
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease. Urology (1999) 1.11
Vegetable-rich food pattern is related to obesity in China. Int J Obes (Lond) (2008) 1.11
Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN J Parenter Enteral Nutr (1987) 1.11
High developmental rates of vitrified bovine oocytes following parthenogenetic activation, in vitro fertilization, and somatic cell nuclear transfer. Biol Reprod (2000) 1.11
Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy. Hum Pathol (1996) 1.11
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology (1999) 1.10